Stock EBAC EURO BIOT
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases EURO BIOT

Equities

EBAC

KYG3167F1028

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-06-25 EDT 		5-day change 1st Jan Change
11.82 USD -0.30% Intraday chart for EURO BIOT +0.64% +5.67%
2023 European Biotech Acquisition Corp.(NasdaqCM:EBAC) dropped from NASDAQ Composite Index CI
2023 Oculis SA completed the acquition of European Biotech Acquisition Corp. from Lsp Sponsor Ebac B.V. and others in a reverse merger. CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
EUROPEAN BIOTECH ACQUISITION CORP. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
EUROPEAN BIOTECH ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
AQ
EUROPEAN BIOTECH ACQUISITION CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
EUROPEAN BIOTECH ACQUISITION CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
EUROPEAN BIOTECH ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
EUROPEAN BIOTECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
European Biotech Acquisition : Oculis SA and European Biotech Acquisition Corp announce business combination agreement to create Nasdaq-listed biopharmaceutical company driving breakthrough innovations in ophthalmology - Form 8-K
PU
EUROPEAN BIOTECH ACQUISITION CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
EUROPEAN BIOTECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
EUROPEAN BIOTECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
EUROPEAN BIOTECH ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
AQ
EUROPEAN BIOTECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
EUROPEAN BIOTECH ACQUISITION CORP. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
AQ
EUROPEAN BIOTECH ACQUISITION : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
EUROPEAN BIOTECH ACQUISITION : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
European Biotech Acquisition Corp. : Receives Expected Notification from Nasdaq Related to Delayed Quarterly Report
BU
European Biotech Acquisition : Receives Expected Notification from Nasdaq Related to Delayed Quarterly Report (Form 8-K)
PU
EUROPEAN BIOTECH ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EBAC Stock
  4. News EURO BIOT
  5. Press Releases